33/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q20/3 |
LoseLAB / S&P -10.87% / 15.20% |
LoseLAB / S&P -4.78% / 15.00% |
LoseLAB / S&P -170.97% / 50.40% |
Non-scoringLAB / S&P 100.37% / 15.70% | Non-scoringLAB / S&P 3.79 / 28.47 | Non-scoringLAB / S&P 0.60 / S&P unavailable | Non-scoringLAB / S&P LAB unavailable / S&P unavailable | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.36b |
| 2026-Q10/3 |
LoseLAB / S&P -28.13% / -4.33% |
LoseLAB / S&P -3.71% / 11.30% |
LoseLAB / S&P -158.82% / 27.70% |
Non-scoringLAB / S&P 90.67% / 14.80% | Non-scoringLAB / S&P 4.59 / 25.43 | Non-scoringLAB / S&P 0.64 / S&P unavailable | Non-scoringLAB / S&P LAB unavailable / S&P unavailable | Non-scoringLAB / S&P LAB unavailable / $0.27b | Non-scoringLAB / S&P LAB unavailable / $0.00b |
| 2025-Q40/3 |
LoseLAB / S&P -1.54% / 2.65% |
LoseLAB / S&P -25.73% / 9.00% |
LoseLAB / S&P -62.96% / 13.40% |
Non-scoringLAB / S&P -87.77% / 13.20% | Non-scoringLAB / S&P LAB unavailable / 28.48 | Non-scoringLAB / S&P 1.17 / 5.39 | Non-scoringLAB / S&P LAB unavailable / $4.42m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.20b |
| 2025-Q31/3 |
WinLAB / S&P 8.33% / 8.12% |
LoseLAB / S&P -27.04% / 4.61% |
LoseLAB / S&P -53.52% / 13.45% |
Non-scoringLAB / S&P -148.59% / 11.78% | Non-scoringLAB / S&P LAB unavailable / 28.13 | Non-scoringLAB / S&P 1.25 / 5.27 | Non-scoringLAB / S&P LAB unavailable / $4.42m | Non-scoringLAB / S&P LAB unavailable / $0.11b | Non-scoringLAB / S&P LAB unavailable / $0.00b |
| 2025-Q21/3 |
WinLAB / S&P 11.11% / 10.94% |
LoseLAB / S&P -26.93% / 4.83% |
LoseLAB / S&P -65.93% / 10.63% |
Non-scoringLAB / S&P -135.63% / 11.45% | Non-scoringLAB / S&P LAB unavailable / 27.10 | Non-scoringLAB / S&P 1.08 / 5.01 | Non-scoringLAB / S&P LAB unavailable / $4.42m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.23b |
| 2025-Q10/3 |
LoseLAB / S&P -38.29% / -4.27% |
LoseLAB / S&P -29.33% / 4.98% |
LoseLAB / S&P -66.34% / 10.57% |
Non-scoringLAB / S&P -148.21% / 11.39% | Non-scoringLAB / S&P LAB unavailable / 26.23 | Non-scoringLAB / S&P 0.90 / 4.69 | Non-scoringLAB / S&P LAB unavailable / $4.42m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.10b |
| 2024-Q41/3 |
LoseLAB / S&P -9.33% / 2.41% |
WinLAB / S&P 8.04% / 5.25% |
LoseLAB / S&P -43.16% / 6.15% |
Non-scoringLAB / S&P -120.88% / 11.29% | Non-scoringLAB / S&P LAB unavailable / 28.60 | Non-scoringLAB / S&P 1.40 / 4.99 | Non-scoringLAB / S&P LAB unavailable / $4.28m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.08b |
| 2024-Q32/3 |
WinLAB / S&P 9.04% / 5.89% |
WinLAB / S&P 12.49% / 5.89% |
LoseLAB / S&P -26.04% / 6.11% |
Non-scoringLAB / S&P -105.31% / 10.87% | Non-scoringLAB / S&P LAB unavailable / 28.09 | Non-scoringLAB / S&P 1.47 / 4.94 | Non-scoringLAB / S&P LAB unavailable / $4.28m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.21b |
| 2024-Q21/3 |
LoseLAB / S&P -34.69% / 4.28% |
WinLAB / S&P 15.30% / 5.38% |
LoseLAB / S&P -14.15% / 5.12% |
Non-scoringLAB / S&P -97.58% / 10.85% | Non-scoringLAB / S&P LAB unavailable / 27.64 | Non-scoringLAB / S&P 1.29 / 4.79 | Non-scoringLAB / S&P LAB unavailable / $4.28m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.36b |
| 2024-Q12/3 |
WinLAB / S&P 22.62% / 10.56% |
WinLAB / S&P 31.27% / 5.71% |
LoseLAB / S&P -39.16% / 5.59% |
Non-scoringLAB / S&P -70.98% / 10.81% | Non-scoringLAB / S&P LAB unavailable / 27.02 | Non-scoringLAB / S&P 1.79 / 4.71 | Non-scoringLAB / S&P LAB unavailable / $4.28m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.12b |
| 2023-Q41/3 |
LoseLAB / S&P -23.79% / 11.69% |
WinLAB / S&P 8.57% / 6.81% |
LoseLAB / S&P -61.07% / 7.78% |
Non-scoringLAB / S&P -70.21% / 11.19% | Non-scoringLAB / S&P LAB unavailable / 24.35 | Non-scoringLAB / S&P LAB unavailable / 4.31 | Non-scoringLAB / S&P LAB unavailable / $4.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.01b |
| 2023-Q31/3 |
WinLAB / S&P 50.26% / -3.27% |
LoseLAB / S&P -3.68% / 7.52% |
LoseLAB / S&P -58.26% / -5.03% |
Non-scoringLAB / S&P -72.00% / 10.84% | Non-scoringLAB / S&P LAB unavailable / 23.93 | Non-scoringLAB / S&P LAB unavailable / 3.98 | Non-scoringLAB / S&P LAB unavailable / $4.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.24b |
| 2023-Q20/3 |
LoseLAB / S&P -1.03% / 8.74% |
LoseLAB / S&P -5.89% / 9.50% |
LoseLAB / S&P -49.76% / -8.57% |
Non-scoringLAB / S&P -79.80% / 10.88% | Non-scoringLAB / S&P LAB unavailable / 24.01 | Non-scoringLAB / S&P LAB unavailable / 4.19 | Non-scoringLAB / S&P LAB unavailable / $4.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.17b |
| 2023-Q12/3 |
WinLAB / S&P 66.67% / 7.50% |
LoseLAB / S&P -22.31% / 10.77% |
WinLAB / S&P 9.21% / -15.69% |
Non-scoringLAB / S&P -135.30% / 10.82% | Non-scoringLAB / S&P LAB unavailable / 22.66 | Non-scoringLAB / S&P LAB unavailable / 3.93 | Non-scoringLAB / S&P LAB unavailable / $4.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.13b |
| 2022-Q41/3 |
LoseLAB / S&P 6.36% / 7.56% |
LoseLAB / S&P -24.99% / 11.88% |
WinLAB / S&P 212.82% / -17.99% |
Non-scoringLAB / S&P -194.08% / 11.09% | Non-scoringLAB / S&P LAB unavailable / 22.65 | Non-scoringLAB / S&P LAB unavailable / 3.75 | Non-scoringLAB / S&P LAB unavailable / $3.70m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.15b |
| 2022-Q31/3 |
LoseLAB / S&P -31.25% / -4.88% |
LoseLAB / S&P -20.25% / 13.47% |
WinLAB / S&P 152.75% / -1.41% |
Non-scoringLAB / S&P -163.64% / 12.28% | Non-scoringLAB / S&P LAB unavailable / 20.58 | Non-scoringLAB / S&P LAB unavailable / 3.60 | Non-scoringLAB / S&P LAB unavailable / $3.70m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.17b |
| 2022-Q21/3 |
LoseLAB / S&P -55.43% / -16.10% |
LoseLAB / S&P -24.43% / 13.71% |
WinLAB / S&P 160.49% / 11.04% |
Non-scoringLAB / S&P -145.56% / 13.03% | Non-scoringLAB / S&P LAB unavailable / 20.28 | Non-scoringLAB / S&P LAB unavailable / 3.78 | Non-scoringLAB / S&P LAB unavailable / $3.70m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.17b |
| 2022-Q11/3 |
LoseLAB / S&P -8.42% / -4.60% |
LoseLAB / S&P -13.28% / 15.97% |
WinLAB / S&P 100.00% / 42.23% |
Non-scoringLAB / S&P -93.89% / 14.22% | Non-scoringLAB / S&P LAB unavailable / 22.19 | Non-scoringLAB / S&P 12.53 / 4.51 | Non-scoringLAB / S&P LAB unavailable / $3.70m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.20b |
| 2021-Q40/3 |
LoseLAB / S&P -40.52% / 11.03% |
LoseLAB / S&P -5.47% / 15.00% |
LoseLAB / S&P LAB unavailable / 96.40% |
Non-scoringLAB / S&P -45.36% / 15.13% | Non-scoringLAB / S&P LAB unavailable / 23.63 | Non-scoringLAB / S&P 3.19 / 4.73 | Non-scoringLAB / S&P LAB unavailable / $3.63m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.13b |
| 2021-Q31/3 |
WinLAB / S&P 6.98% / 0.58% |
LoseLAB / S&P 8.69% / 10.77% |
LoseLAB / S&P LAB unavailable / 69.42% |
Non-scoringLAB / S&P -49.54% / 14.13% | Non-scoringLAB / S&P LAB unavailable / 25.35 | Non-scoringLAB / S&P 5.07 / 4.38 | Non-scoringLAB / S&P LAB unavailable / $3.63m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.19b |
| 2021-Q22/3 |
WinLAB / S&P 36.28% / 8.55% |
WinLAB / S&P 31.68% / 6.58% |
LoseLAB / S&P LAB unavailable / 51.81% |
Non-scoringLAB / S&P -40.46% / 13.34% | Non-scoringLAB / S&P LAB unavailable / 26.70 | Non-scoringLAB / S&P 4.29 / 4.43 | Non-scoringLAB / S&P LAB unavailable / $3.63m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.11b |
| 2021-Q11/3 |
LoseLAB / S&P -24.67% / 6.17% |
WinLAB / S&P 24.90% / -1.06% |
LoseLAB / S&P LAB unavailable / 7.39% |
Non-scoringLAB / S&P -38.98% / 11.60% | Non-scoringLAB / S&P LAB unavailable / 30.50 | Non-scoringLAB / S&P 2.76 / 4.23 | Non-scoringLAB / S&P LAB unavailable / $3.63m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.10b |
| 2020-Q41/3 |
LoseLAB / S&P -19.25% / 12.15% |
WinLAB / S&P 17.83% / -3.72% |
LoseLAB / S&P LAB unavailable / -33.42% |
Non-scoringLAB / S&P -38.38% / 8.86% | Non-scoringLAB / S&P LAB unavailable / 39.26 | Non-scoringLAB / S&P 3.22 / 4.05 | Non-scoringLAB / S&P LAB unavailable / $3.17m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.01b |
| 2020-Q32/3 |
WinLAB / S&P 85.29% / 8.93% |
WinLAB / S&P 7.55% / -2.04% |
LoseLAB / S&P LAB unavailable / -27.10% |
Non-scoringLAB / S&P -37.85% / 9.24% | Non-scoringLAB / S&P LAB unavailable / 34.27 | Non-scoringLAB / S&P 3.62 / 3.65 | Non-scoringLAB / S&P LAB unavailable / $3.17m | Non-scoringLAB / S&P LAB unavailable / $0.02b | Non-scoringLAB / S&P LAB unavailable / $0.00b |
| 2020-Q21/3 |
WinLAB / S&P 57.87% / 20.54% |
LoseLAB / S&P -5.84% / -0.46% |
LoseLAB / S&P LAB unavailable / -27.11% |
Non-scoringLAB / S&P -48.46% / 9.37% | Non-scoringLAB / S&P LAB unavailable / 31.29 | Non-scoringLAB / S&P 2.15 / 3.44 | Non-scoringLAB / S&P LAB unavailable / $3.17m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.03b |
| 2020-Q10/3 |
LoseLAB / S&P -27.01% / -19.60% |
LoseLAB / S&P -2.61% / 3.47% |
LoseLAB / S&P LAB unavailable / -14.75% |
Non-scoringLAB / S&P -48.20% / 10.68% | Non-scoringLAB / S&P LAB unavailable / 22.80 | Non-scoringLAB / S&P 1.27 / 2.92 | Non-scoringLAB / S&P LAB unavailable / $3.17m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.05b |
| 2019-Q40/3 |
LoseLAB / S&P -24.84% / 9.07% |
LoseLAB / S&P 3.79% / 5.36% |
LoseLAB / S&P LAB unavailable / 2.99% |
Non-scoringLAB / S&P -55.26% / 12.81% | Non-scoringLAB / S&P LAB unavailable / 22.78 | Non-scoringLAB / S&P 1.58 / 3.53 | Non-scoringLAB / S&P LAB unavailable / $3.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.05b |
| 2019-Q31/3 |
LoseLAB / S&P -62.42% / 1.70% |
WinLAB / S&P 8.07% / 5.02% |
LoseLAB / S&P LAB unavailable / 0.21% |
Non-scoringLAB / S&P -57.10% / 12.41% | Non-scoringLAB / S&P LAB unavailable / 22.44 | Non-scoringLAB / S&P 1.98 / 3.30 | Non-scoringLAB / S&P LAB unavailable / $3.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.09b |
| 2019-Q21/3 |
LoseLAB / S&P -7.30% / 4.30% |
WinLAB / S&P 14.81% / 6.64% |
LoseLAB / S&P LAB unavailable / 8.65% |
Non-scoringLAB / S&P -57.48% / 12.79% | Non-scoringLAB / S&P LAB unavailable / 21.37 | Non-scoringLAB / S&P 4.95 / 3.32 | Non-scoringLAB / S&P LAB unavailable / $3.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.27b |
| 2019-Q12/3 |
WinLAB / S&P 54.18% / 13.65% |
WinLAB / S&P 15.91% / 8.12% |
LoseLAB / S&P LAB unavailable / 14.29% |
Non-scoringLAB / S&P -60.45% / 12.97% | Non-scoringLAB / S&P LAB unavailable / 20.86 | Non-scoringLAB / S&P 5.03 / 3.26 | Non-scoringLAB / S&P LAB unavailable / $3.08m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $34.35b |
| 2018-Q42/3 |
WinLAB / S&P 15.09% / -13.52% |
WinLAB / S&P 10.82% / 9.05% |
LoseLAB / S&P LAB unavailable / 18.23% |
Non-scoringLAB / S&P -52.24% / 13.10% | Non-scoringLAB / S&P LAB unavailable / 19.39 | Non-scoringLAB / S&P 5.90 / 2.94 | Non-scoringLAB / S&P LAB unavailable / $3.00m | Non-scoringLAB / S&P LAB unavailable / $0.01b | Non-scoringLAB / S&P LAB unavailable / $0.00b |
| 2018-Q31/3 |
WinLAB / S&P 25.67% / 7.71% |
LoseLAB / S&P 9.17% / 10.21% |
LoseLAB / S&P LAB unavailable / 19.06% |
Non-scoringLAB / S&P -50.46% / 13.01% | Non-scoringLAB / S&P LAB unavailable / 22.25 | Non-scoringLAB / S&P 13.14 / 3.45 | Non-scoringLAB / S&P LAB unavailable / $3.00m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.17b |
| 2018-Q20/3 |
LoseLAB / S&P 2.05% / 3.43% |
LoseLAB / S&P 7.70% / 9.03% |
LoseLAB / S&P LAB unavailable / 14.46% |
Non-scoringLAB / S&P -53.65% / 12.56% | Non-scoringLAB / S&P LAB unavailable / 22.49 | Non-scoringLAB / S&P 6.70 / 3.25 | Non-scoringLAB / S&P LAB unavailable / $3.00m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.19b |
| 2018-Q10/3 |
LoseLAB / S&P -0.85% / -0.76% |
LoseLAB / S&P 0.67% / 7.68% |
LoseLAB / S&P LAB unavailable / 12.46% |
Non-scoringLAB / S&P -55.66% / 12.27% | Non-scoringLAB / S&P LAB unavailable / 23.41 | Non-scoringLAB / S&P 4.68 / 3.17 | Non-scoringLAB / S&P LAB unavailable / $3.00m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.08b |
| 2017-Q41/3 |
WinLAB / S&P 16.87% / 6.64% |
LoseLAB / S&P -2.40% / 7.03% |
LoseLAB / S&P LAB unavailable / 13.82% |
Non-scoringLAB / S&P -59.39% / 12.09% | Non-scoringLAB / S&P LAB unavailable / 24.25 | Non-scoringLAB / S&P 7.30 / 3.23 | Non-scoringLAB / S&P LAB unavailable / $2.92m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.05b |
| 2017-Q31/3 |
WinLAB / S&P 24.75% / 4.48% |
LoseLAB / S&P -9.82% / 5.68% |
LoseLAB / S&P LAB unavailable / 17.57% |
Non-scoringLAB / S&P -68.27% / 12.04% | Non-scoringLAB / S&P LAB unavailable / 23.28 | Non-scoringLAB / S&P 4.98 / 3.08 | Non-scoringLAB / S&P LAB unavailable / $2.92m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.11b |
| 2017-Q20/3 |
LoseLAB / S&P -29.00% / 3.09% |
LoseLAB / S&P -17.00% / 4.83% |
LoseLAB / S&P LAB unavailable / 17.74% |
Non-scoringLAB / S&P -74.05% / 11.96% | Non-scoringLAB / S&P LAB unavailable / 23.40 | Non-scoringLAB / S&P 4.96 / 3.03 | Non-scoringLAB / S&P LAB unavailable / $2.92m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.08b |
| 2017-Q10/3 |
LoseLAB / S&P -21.84% / 6.07% |
LoseLAB / S&P -13.69% / 3.67% |
LoseLAB / S&P LAB unavailable / 13.32% |
Non-scoringLAB / S&P -72.60% / 11.75% | Non-scoringLAB / S&P LAB unavailable / 23.60 | Non-scoringLAB / S&P 4.33 / 3.01 | Non-scoringLAB / S&P LAB unavailable / $2.92m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $20.24b |
| 2016-Q40/3 |
LoseLAB / S&P -9.11% / 3.82% |
LoseLAB / S&P -8.95% / 2.09% |
LoseLAB / S&P LAB unavailable / 7.05% |
Non-scoringLAB / S&P -72.75% / 11.37% | Non-scoringLAB / S&P LAB unavailable / 23.76 | Non-scoringLAB / S&P 3.99 / 2.91 | Non-scoringLAB / S&P LAB unavailable / $2.88m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $1.11b |
| 2016-Q30/3 |
LoseLAB / S&P -11.30% / 3.85% |
LoseLAB / S&P -6.30% / 0.20% |
LoseLAB / S&P LAB unavailable / -3.15% |
Non-scoringLAB / S&P -64.65% / 10.82% | Non-scoringLAB / S&P LAB unavailable / 24.22 | Non-scoringLAB / S&P 3.43 / 2.78 | Non-scoringLAB / S&P LAB unavailable / $2.88m | Non-scoringLAB / S&P LAB unavailable / $0.00b | Non-scoringLAB / S&P LAB unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -48.41% | 20.78% |
| Annualized return | -48.41% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -91.00% | 83.14% |
| Annualized return | -38.22% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | LAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -92.61% | 319.30% |
| Annualized return | -22.93% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.